1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
64EB178AC64F9DC0985257BB000606686
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/consumer-marketing-research-innovation-communication-tactics-and-trends-for-reaching-consumers?opendocument
18
19opendocument
2044.222.134.250
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Market Research, Analytics and Forecasting » Process Excellence and Productivity Management

Consumer Marketing Research Innovation: Communication Tactics and Trends for Reaching Consumers

ID: 5258


Features:

13 Info Graphics

15 Data Graphics

200+ Metrics

5 Narratives


Pages/Slides: 35


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Consumer Marketing Research Innovation: Communication Tactics and Trends for Reaching Consumers"


STUDY OVERVIEW

Technology advances continue to influence how organizations communicate with consumers and influence their purchasing decisions. At the same time, old standbys like publications and education in the marketplace continue to play an important role in informing consumers. Across industry sectors companies are finding success by focusing their communication efforts across a broad platform of tools and tactics that utilize both new technologies and more standard approaches.

Best Practices, LLC conducted this cross-industry benchmarking study to identify current and evolving approaches for consumer marketing and communication. This study presents data on the consumer communication tactics that organizations find most effective and which tools and tactics participants expect to be utilizing more in the next 1-3 years.

This study includes data on three segments: pharmaceutical companies, non-pharmaceutical companies and the Total Benchmark Class.

KEY TOPICS

  • Consumer Communication Preferences
  • Pharma Communication Preferences
  • Non-Pharma Communication Preferences
  • Trends in Consumer Communication
  • Pharma Trends in Consumer Communication
  • Non-Pharma Trends in Consumer Communication

SAMPLE KEY METRICS
  • Effectiveness of various tools, technologies and channels that you use to communicate, educate, and inform consumers (Total Benchmark Class)
  • Effectiveness of various tools, technologies and channels that you use to communicate, educate, and inform consumers (Pharma)
  • Effectiveness of various tools, technologies and channels that you use to communicate, educate, and inform consumers (Non-Pharma)
  • Usage trends for consumer education & communication tools and channels (Total Benchmark Class)
  • Usage trends for consumer education & communication tools and channels (Pharma)
  • Usage trends for consumer education & communication tools and channels (Non-Pharma)
  • Innovative combinations of existing market research tools or techniques that have produced valuable insights


SAMPLE KEY FINDING
  • Utilization – Search Engine Marketing Expected to Grow the Most in Next 1 to 3 Years: In terms of utilization trends, the use of search engine marketing and social media appear poised to grow the most in the next 1 to 3 years. Thirty percent of all participants said they expect SEM use to grow more than 10% during that period while another 22% expect it to grow up to 10%. Interestingly, while only 8% see social media as a very effective communication tool, over the next 1 to 3 years 21% expect it to grow in use by more than 10% and another 57% expect its use to increase by up to 10%. A majority of participants expect the use of 6 of the 11 communication tools measured to remain the same over the next 1 to 3 years.

STUDY METHODOLOGY


Fifty-nine benchmark survey respondents from 58 companies participated in this study. In addition, research analysts conducted executive interviews with eight selected respondents to collect qualitative data and insights.

Industries Profiled:
Pharmaceutical; Health Care; Market Research; Marketing; Service; Transportation; Insurance; Advertising; Biotech; Biopharmaceutical; Clinical Research; Laboratories; Utilities; Consulting; Manufacturing; Financial Services; Telecommunications; Education; Real Estate; Electronics; Computer Hardware; Computer Software; Communications; Medical Device; Professional Services; Consumer Products


Companies Profiled:
Grifols; HIT Global; Sample Answers; Lifestyle Marketing; Veeda Clinical Research; Metropolitan; Midwest Employers Casualty Company; Catalpha; Sanofi; SMUD; ic axon; SCL Systems Consulting; Coleman; The SoNo Group; DDI; IBS; Merck Serono; uatae; National Housing Trust; MTS; Daiichi Sankyo; Sekisanchi ; Landmark Group; Emirates Post; Ferring Pharmaceuticals; 20/20 Research; CDW; Quadra; GE Healthcare; vetoquinol; synergesic; Independence Blue Cross; ARIAD; gemalto; Teva Neuroscience; Klick Health; EMD Serono; EPR; Merck; Bright Horizons; Teva Pharmaceutical Industries Ltd; R2Business Solutions; Janssen; brunner; Novo Nordisk; Zillner; Johnson & Johnson; HFS Research; Biogen Idec; Medtronic; UCB Pharma; American Dental Association; Maxcom; China HR Insight; Convergys; Unilever; MidAmerican Energy Company; Emirates Group

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.